We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns API Manufacturer ChemPacific for Quality Issues
FDA Warns API Manufacturer ChemPacific for Quality Issues
July 5, 2011
The FDA has warned active pharmaceutical ingredient (API) manufacturer ChemPacific for GMP deviations, with citations related to documentation and written procedures.